RICHARD BOND to Drug Design
This is a "connection" page, showing publications RICHARD BOND has written about Drug Design.
Connection Strength
0.120
-
Inverse agonism: from curiosity to accepted dogma, but is it clinically relevant? Curr Opin Pharmacol. 2007 Apr; 7(2):146-50.
Score: 0.062
-
Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery. Trends Pharmacol Sci. 2006 Feb; 27(2):92-6.
Score: 0.058